U.K. researchers say the cheap, widely available steroid dexamethasone reduced deaths by up to one-third in severely ill hospitalized patients.
Coming up with the number is one thing. Seizing that cash, experts agree, is another matter entirely.
Some experts doubt that the rule would have been capable of lowering drug prices.
We remember anti-drug PSAs for reasons their makers didn't intend.
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an anesthetic that’s sometimes used recreationally and often known as “Special K.” Because ketamine can cause […]
Is losing the leader of a drug-trafficking organization bad for business?
Bristol-Myers Squibb announced Thursday that it’s going to acquire another drugmaker, Celgene. The deal is worth about $74 billion. The combined company will have nine products with sales of more than a billion dollars a year, including some blockbuster cancer drugs. The merger is a sign that Big Pharma is betting big on cancer medications. […]
The trade agreement reached over the weekend between the U.S., Canada and Mexico includes longer intellectual property protection periods for the expensive class of drugs known as biologics.
Across the country, hospitals and clinics are dealing with a really difficult problem: Sometimes they can’t get their hands on certain life-saving generic drugs. So one group of large hospital systems, including the Mayo Clinic and Intermountain Healthcare, has come up with a workaround. It’s created a nonprofit company called Civica RX that will make […]